ADMA Biologics, Inc.
NASDAQ:ADMA · NASDAQ Global Market
+$0.04 today
Vol 6.84M · Avg 7.07M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-53.50%
Period High
$20.38
Period Low
$7.60
Latest
$8.31
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$5.84B
Belite Bio, Inc
NASDAQ:BLTE
$5.78B
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
$5.35B
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
$5.27B
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$3.74B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.65B
Telix Pharmaceuticals Limited
NASDAQ:TLX
$3.40B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.22B
Soleno Therapeutics, Inc.
SLNO
$2.76B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.73B
What is the latest ADMA filing?
The latest filing shown is 8-K dated Jun 2, 2026.
How many recent filings does ADMA have?
Intrinsic Alpha currently shows 20 recent filings for ADMA.
Explore More
Continue the stock analysis
Jump to another research area for this company.